|
|
|
Volumn 22, Issue 9, 2007, Pages 103-
|
|
FDA notifications. Maraviroc approved as a CCR5 co-receptor antagonist.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHEMOKINE RECEPTOR CCR5;
CYCLOHEXANE DERIVATIVE;
HUMAN IMMUNODEFICIENCY VIRUS FUSION INHIBITOR;
MARAVIROC;
TRIAZOLE DERIVATIVE;
ARTICLE;
DRUG ANTAGONISM;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LEGAL ASPECT;
UNITED STATES;
VIRUS LOAD;
CYCLOHEXANES;
DRUG APPROVAL;
HIV FUSION INHIBITORS;
HIV INFECTIONS;
HUMANS;
RECEPTORS, CCR5;
TRIAZOLES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
VIRAL LOAD;
|
|
EID: 42949176815
PISSN: 08870292
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (9)
|
|
References (0)
|